Dekel Pharmaceuticals
Compositions for Inflammatory Disorders
Health Tech & Life Sciences
Acquired (Inactive) by SciSparc on Oct 2014 - closed due to acquisition
Company Overview
Snapshot
Founded in October 2008, Dekel Pharmaceuticals operates with 1–10 employees. The company was acquired by SciSparc in October 2014, marking a significant milestone in its trajectory.
Business overview
Dekel Pharmaceuticals Ltd specializes in the development of compositions and methods for treating inflammatory disorders. The company's core technology focuses on addressing these conditions, serving the pharmaceutical and life sciences industries within the broader Health Tech & Life Sciences sector.
Company Intelligence Q&A
- What is Dekel Pharmaceuticals' primary focus?
- Dekel Pharmaceuticals Ltd develops compositions and methods for the treatment of inflammatory disorders.
- When was Dekel Pharmaceuticals founded?
- Dekel Pharmaceuticals was founded in October 2008.
- What is the current status of Dekel Pharmaceuticals?
- Dekel Pharmaceuticals was acquired by SciSparc in October 2014 and is currently inactive.
- Which sector does Dekel Pharmaceuticals operate in?
- Dekel Pharmaceuticals operates within the Health Tech & Life Sciences sector, specifically focusing on Pharma & Medical Biotechnology and Drugs Discovery & Development.
- What type of business model does Dekel Pharmaceuticals utilize?
- Dekel Pharmaceuticals primarily uses a B2B business model.